Who
Viviane Monges
Director
Company insider
Files Form 4 as: Director, Pharvaris; Director, ADC Therapeutics SA; Director, DBV Technologies.
In numbers
- Trades disclosed
- 17
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $1.4M
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 10 Jun 2021
- Last trade
- 23 Sep 2026
- Last filed
- 25 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 23 Sep 2026filed 25 Sep 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Code M | $96K11,969 at $8.05 | filing |
| 23 Sep 2026filed 25 Sep 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $396K11,969 at $33.05 | filing |
| 23 Sep 2026filed 25 Sep 2026 | PHVS Pharvarisoption or derivative · Biotechnology | SEC FORM 4 Code M | —11,969 at $0.00 | filing |
| 23 Sep 2026filed 25 Sep 2026 | PHVS Pharvarisoption or derivative · Biotechnology | SEC FORM 4 Code M | —11,969 at $0.00 | filing |
| 23 Sep 2026filed 25 Sep 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Code M | $96K11,969 at $8.05 | filing |
| 23 Sep 2026filed 25 Sep 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $396K11,969 at $33.05 | filing |
| 3 Jun 2026filed 3 Jun 2026 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Code F | $7,9962,596 at $3.08 | filing |
| 3 Jun 2026filed 3 Jun 2026 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Code F | $7,9962,596 at $3.08 | filing |
| 1 Jun 2026filed 3 Jun 2026 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $293K9,667 at $30.29 | filing |
| 21 May 2026filed 26 May 2026 | PHVS PharvarisBiotechnology | SEC FORM 4 Sold | $293K9,667 at $30.29 | filing |
| 13 Jun 2025filed 17 Jun 2025 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Code F | $9,2512,584 at $3.58 | filing |
| 3 Jun 2025filed 5 Jun 2025 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 17 Jun 2024filed 18 Jun 2024 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Sold | $4,1531,437 at $2.89 | filing |
| 13 Jun 2024filed 14 Jun 2024 | ADCT ADC Therapeutics SABiotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 10 Jun 2021filed 11 Jun 2021 | DBVT DBV Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code P | $36K5,000 at $7.12 | filing |
News
No headline names them, or the companies they trade most, lately.